Search results

Press Release

Altasciences Completes Clinical Portion of Alzamend Neuro's Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer's

Apr 18, 2023
Blog

2022 Year in Review

Dec 26, 2022
Press Release

Altasciences Receives Accreditation From College of American Pathologists

Oct 31, 2022
Press Release

Altasciences Expands Laboratory Capabilities in Columbia

Oct 17, 2022
Press Release

Altasciences Expands Strategic Support for Early Drug Development in Europe and Adds Key Employees to Its Preclinical Team in North America

Oct 13, 2022
Press Release

Hoth Therapeutics Announces the Selection of Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke

Sep 20, 2022
Scientific Publication

Altasciences' Proactive Drug Development Solution: Small Molecules

Sep 16, 2022
- End-to-End Program